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As societies industrialize, the health profile of the population changes; in general, acute infectious disease declines and chronic disease increases.
Use of electricity is a hallmark of the industrialization process, but there has been no suspicion that electricity could increase the risk of cancer.
Recently, however, a number of epidemiologic studies have suggested that electromagnetic fields (EMF) may do just that. Although few cancer
experiments have been done yet, there are a number of biological effects of EMF reported in the literature that might provide bases for designing
cancer experiments and epidemiologic studies. These include effects of EMF on: a) DNA transcription and translation, b) calcium balance in cells,
and c) pineal production of melatonin. Alterations in DNA transcription and translation could have pleiotropic effects. Disruption of calcium home-
ostasis has many implications including oncogene activation, promotional activity via protein kinases and ornithine decarboxylase (ODC), and increas-
ing oxidative stress. Reduction of melatonin suggests a possible increased risk of cancers of hormone-dependent tissues such as breast and
prostate. The idea that a cancer-causing agent must either be an initiator or a promoter should be discarded; indeed, the phenomenologic meaning
of these two terms has become confused with imputed mechanistic necessity in recent years. Agents that affect division of normal cells or of fully
transformed cells can play an important role in clinical cancer development quite apart from initiation or promotion. Epidemiologic studies of EMF
and cancer should attempt to take account of other products of electric power (e.g., light at night) or factors associated with occupational EMF expo-
sure (e.g., toxic chemicals) that may increase cancer risk and therefore act as cofactors or confounders. Epidemiology and laboratory studies should
act synergistically in determining if there is a problem and identifying mitigation strategies if needed. - Environ Health Perspect 101(Suppl
4):93-100 (1993).
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Introduction
Industrialization is associated with changes in
the health status of a population. There are
large differences among countries in the rates
of cancer ofspecific sites (1). The ratio of
colon cancer incidence in Connecticut (high
rates) to that in Nigeria (low rates) is 10; the
ratio of breast cancer incidence in Canada
(high rates) to that in the non-Jews in Israel
(low rates) is 7. Total cancer incidence varies
by about 3-fold among countries. Migrants
from one area take on the cancer rates oftheir
new homes, and there are known, or strongly
suspected, causes of some of the most com-
mon cancers in eachsociety such ashepatitis B
virus and liver cancer in Taiwan, and cigarette
smoking and lung cancer in the United States.
Theseobservations suggest racial factors do not
account for the law variations in cancer risk
around the world. Rather, lifestyle is believed
to play a major role in cancer occurrence.
However, it is not dear how much ofthevari-
ation in risks can be accounted for by specific
lifestyles. At one extreme is the confidence
that cigarette smoking accounts for 90% of
lung cancer in high risk societies; at the other
extreme is the lackofunderstanding ofsocietal
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differences in stomach cancer risk and why it
has declined in the industrialized world.
Understandingofbreastcancerliessomewhere
in the middle. Although major risk factors
have been identified for breast cancer, they do
notappeartoaccountfortheobservedinterna-
tionalvariation inbreast cancer rates (2). The
reason for the large differences in risk among
countries remainsamystery.
Until recendy there was no suspicion that
any aspect ofthe use ofelectric power might
play a role in explaining cancer differences
among societies. Motivated by the seminal,
although limited, observations ofWertheimer
and Leeper (3,4) and by recently emerging
evidence for biological effects ofelectromag-
netic fields (EMF) from the laboratory (5),
interest in the possible role ofelectric power
in cancerriskhas increaseddramatically.
This paper is deliberately speculative and
suggests new avenues for epidemiological
inquiry. Biological effects of EMF are
described then reexamined after a presenta-
tion of the two-stage model for cancer (6)
in order to determine how the biology
might relate to carcinogenesis. Implications
for timing of exposure, cancer types, cofac-
tors (effect modifiers), and confounders in
epidemiologic studies aresuggested.
EMF Biological Effects
The biophysical mechanisms ofinteraction of
EMF with biological systems is the subject of
intense interest, but isbeyond thescopeofthis
paper (7-10). Many biological effects of
EMF have been reported in the literature over
theyears and it is not possible here to evaluate
each fairlyas it might affectcancer risk. Many
ofthese are single reports that have not yet
been assessed in other laboratories. However,
several biological effects that do have such
implications are discussed as they might relate
to cancer riskand as they might be accommo-
dated in the design ofepidemiological studies.
Thefollowingdikussion isselectiveandbrief.
DNAMutation
There is evidence that EMF does not damage
DNA directly (11,12), although there is one
report ofincreased micronudei production by
50-Hz electric field exposure (13). Effects of
EMF on chromosome segregation might lead
indirectlyto mutation, althoughthispossibility
is in the very early stages ofevaluation. In
addition, there has been very little study of
possibleeffectsofEMF on DNArepair (12).
DNATranscription andTranslation
Although direct DNA damage from EMF
has not been demonstrated, there have been
reports ofaltered mRNAand protein synthe-
sis (14,15). Goodman et al. (16) reported
increased RNA transcription in dipteran sali-
vary gland cells after exposure to a magnetic
field. Alterations in protein synthesis have
also beenobserved, and there is ashift to pro-
teins oflower molecularweightwith ahigher
net charge. These results are consistent with
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a model in which translation ofprotein from
mRNA is interrupted (17). Such an inter-
ruption ofprotein synthesis would be inter-
esting in light ofthe emerging theory ofcell
cyde regulation byacomplexinterplayofRb,
the protein product of the retinoblastoma
antioncogene, with a series ofother nudear
proteins (18). Ifthe interaction ofRb with
other proteins can be disrupted by EMF due
to shortening ofthe polypeptides and conse-
quent changes in conformation, then effects
on cell cyde regulationwouldbeexpected.
Calcium
Since the report by Bawin and Adey (19),
there has been growing interest in the role of
EMF in calcium balance in cells and in ion
flow in general (20). Awindowofeffect that
depends onfrequencyandamplitudeseems to
determine whether EMF will affect calcium
balance (21). This idea was tested by Smith
etal. (22) who reportedthatdiatommobility,
which is dependent on calcium concentration
in the growth medium, can be affected by
EMF at specified frequency-intensity win-
dows. Reese et al. (23) replicated this result
withconsiderablymorevariability inresponse.
Electromagnetic stimulation has been
used clinically to improve bone healing.
Luben et al. (24) examined the biological
mechanisms for this and suggested that the
effects are mediated at the plasma membrane
either by interference with hormone binding
to osteoblasts or by blocking receptor-cydase
coupling in the membrane. They further
speculate that Ca2+ movement may be
involved. Lyle et al. (25) reported that a 13.6
Hz magnetic field with a peak intensity of20
pT doubled calcium uptake ofnormal lym-
phocytes and ofa lymphoma cell line. These
researchers point out that calcium concentra-
tionandintracellulardistribution affects many
cellular functions, in particular the protein
kinase C, which is important to lymphocyte
activationandproliferation.
OmithineDecaboxylase
Ornithine decarboxylase (ODC) is required
forpolyaminebiosynthesis, andlevels ofit are
high in rapidly dividing cells. Tumor pro-
moters such as 12-O-tetradecanoylphorbol-
13-acetate (TPA) rapidly increase ODC
activityin cells. Byus etal. (26) reportedthat
a 1-hr exposure ofseveral different cell lines
to alow-intensity (10 mV/cm) 60-Hzelectric
field increased ODC activity (although still
far below the levels induced by TPA). They
also reported that in Reuber H35 hepatoma
cells, 3 hr ofexposure first led to an increase,
then to a decrease in ODC activity. The
monotonically increasing dose-response that
might be expected from a toxic chemical
model is not evident. Instead, a 1-hr expo-
sure to 10 and to 0.1 mV/cm increased
activity, and 5 and 1 mV/cmhadno effect.
ImmuneFunction
Lyle et al. (27) reported that exposure to a
450-MHz field amplitude modulated at 60
Hz inhibited the toxicityofT-lymphocytes by
20%. The carrier wave had no effect, and
amplitude modulation higher (up to 100 Hz)
andlower (down to 3 Hz) showed less inhibi-
tion than at 60 Hz. Exposure to a 60-Hz
electric field yielded similar results (28).
Effects ofEMF on intracellular calcium con-
centration might account for this inhibition
(25). Experiments in animals have not
shown effects of EMF on immune function
(29). In humans, however, there is a reportof
impaired immune function in aluminum
reduction plant workers who have high mag-
netic field and volatilized aromatic hydrocar-
bonexposurs (30). Thestudywasundertaken
becausefive casesofB-cell lymphomaoccurred
over a 7-year period in an aluminum plant in
Washingtonstatewhenonly0.2wereexpected.
Among23 apparentlyhealthyvolunteers from
this plant, there was a significant increase in
mean T8 and T4 levels, and there was a sig-
nificant alteration in T4/T8 ratios in ten of
the subjects due to disproportionate elevations
ofthe T8 subpopulation. Another investiga-
tion, from Yugoslavia, reported that workers
occupationally exposed to microwaves had
greater numbers of micronuclei and other
genomic abnormalities in a sample of their
peripherallymphocytes thancontrols (31).
PinealFunction
The pineal gland is a neuroendocrine trans-
ducer that provides a hormonal signal syn-
chronized to the daily light and dark cycle
(32). Melatonin, the principal pineal hor-
mone, exerts a generally suppressive action on
other endocrine glands. Reduced circulating
concentrations of melatonin can result in
increasedprolactin releasebythepituitaryand
increased estrogen and testosterone release by
thegonads (33,34). Production ofmelatonin
is suppressed by light perceived by the retina.
Hence, circulating melatonin concentrations
arelowindaylightandhigheratnight (35).
Cohen etal. (36) suggested that reduced
pineal melatonin production might increase
human breast cancer risk because lower
melatonin output would lead to an increase
in circulating estrogen levels and would
stimulate the proliferation of breast tissue.
Indeed, early menarche, late menopause,
and nulliparity are each associated with an
increased risk ofbreast cancer (37), and all
result in a longer period for proliferation of
the breastepithelial stem cells at risk (38).
A number ofinvestigators have reported
that EMF, under some circumstances, can
reduce or suppress melatonin production by
the pineal gland (39-45). These observa-
tionsprovided anatural frameworkforpostu-
lating that EMF may influence risk ofcertain
cancers, in particular breast and prostate can-
cer (4647). Melatonin inhibits the growth
ofDunning prostatic cancercells transplanted
into rats (48), is oncostatic to human breast
cancer cells in vitro (49), and inhibits chemi-
callyinducedbreastcancer in rats (50). Light
at night (LAN) suppresses melatonin produc-
tion (34,51). Thus, two products ofelectric
power, EMF and LAN, may reduce mela-
tonin in humans and influence risks ofbreast
andprostate cancers.
Two groups have reported experiments in
rats inwhich a 50-Hzmagneticfieldincreased
chemically induced mammary cancer yield
(52,53). Beniashvili et al. (52) used a 20-,uT
magnetic field, whereas Mevissen et al.
(unpublished data) used a 100 jT magnetic
field. Should these findings be replicable in
otherlaboratories theywill be important.
Two-Stage Model for
Carcinogenesis
The term carcinogenesisis meant to conveythe
entire process from a beginning with normal
cells in a healthy tissue to an ending with a
diagnosed malignant tumor. The terms initi-
ationandpromotionwereoriginallydefined on
strictly phenomenological grounds: an initia-
tor is an agent that alone does not produce
tumors, yet when followed by a promoter
yields many tumors. A promoter is an agent
that alone yields no tumors, yet when pre-
ceded by an initiator yields many tumors. A
promoter followed by an initiator also yields
no tumors. The tumors on mouse skin origi-
nally used to define initiator and promoter
were not in fact cancer; they were benign
lesions, many, ifnot most, ofwhich regressed
upon cessation ofthe promoter. In the last
two decades, the terms initiator and promoter
have come by some to be used as iftheyoffer
deep insight into theprocessofcarcinogenesis,
as ifacancer-causingagent is eitherone orthe
other, and as if both must be necessary for
cancer to occur. An alternative view is that
the original definitions ofthese agents offer
evidence on the process ofcarcinogenesis, but
do not define it. The following paragraphs
present amodelforcancerandaspecificinter-
pretation ofwhat initiators and promoters are
and how they fit into the larger scheme of
carcinogenesis according to this model.
Offering a definition ofcancer in quanti-
tative or even qualitative terms runs the risk
ofignoring some ormanyofthemyriad char-
acteristics ofcancer that have been reported.
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Figure 1. Two-stage model for cancer, adapted from Moolgavkar and Knudson (6). A normal
cell divides as part of a normal tissue. With small probability, a normal cell may divide to give
one normal and one intermediate cell, which in turn can divide to become an intermediate
lesion. With small probability, an intermediate cell may divide to give one intermediate and
one cancer cell. A promoter greatly increases the chance that a malignant cell will arise by
increasing the pool of intermediate cells.
However, without a model it is difficult to
formulate meaningful studies that might
contribute new understanding. Figure 1 is
adapted from Stevens et al. (54) and depicts
the two-stage model for cancer developed by
Moolgavkar and Knudson (6). This model
is biologically simple without, so far, being
shown to be simplistic; it is currently the
most parsimonious model consistent with
the body ofknowledge on cancer. It pro-
vides an appealing framework within which
to evaluate the potential carcinogenicity ofa
putative cancer-causing agent, and to design
studies based onspecific mechanisms.
Accordingtothemodel, thedriversofcan-
cerappearance are mutations to DNAandthe
growth kinetics ofnormal, intermediate, and
cancercells. Anormalcelldivideswithgrowth
rate A to maintain healthy tumover ofa nor-
mal tissue. 'Vrth lowprobabilityjl, anormal
cell maydivideandproduce anormal cell and
an intermediate cell that has suffered one of
the two DNA mutations required for malig-
nant transformation. This intermediate cell
divideswithgrowth rate B toform an interme-
diate lesion. An intermediate cell may also
divide with low probability 2 to yield an
intermediate cell and a maant cell that has
suffered the second necessary mutation to
DNA. A normal cell may suffer both DNA
mutations at a single division with very low
probability, Ii times P2. Malignant cells can
dividewithgrowth rate C to form amalignant
tumor (i.e., progression). Afterclinicaldiagno-
sis, behavior ofthe tumor is affected by the
dinical treatment aswell as all theendogenous
factorspreviouslyaffectingits growth.
Within thecontextofthetwo-stagemodel,
an initiator is a mutagen delivered atlowdose,
thus increasing mutation rates g andp2, and
the probability ofmutating both ofthe two
genesnecearyfor i anttrnsformation is
low. Apromoter is an agent that increases the
proliferation ofintermediate cells, B (and per-
haps normal cells, A). This increases the
chance thatthesecondmutationwilloccurby,
for example, mitotic recombination ifthe two
events must occur in both homologues ofthe
same gene (e.g., an antioncogene, also known
as atumor-suppressorgene), orbymutationof
a second necessary gene (e.g., a second pro-
tooncogene). Acompletecarcinogen iseithera
mutagen delivered at high dose or an agent
that is both mutagenic and mitogenic. An
intermediate cell may not be subjected to a
promoterbutmaystill sufferthesecond muta-
tion to become malignant (depicted by the
diagonal arrow leading from the single inter-
mediate cell to the single malignant cell in
Figure 1). Apremalignantlesion is aprolifera-
tion ofintermediate cells that areheterozygous
for an antioncogene, or that have only one of
two different and necessary protooncogenes
activated. Amaant tumor is aproliferation
ofmaignant cells which have both necessary
mutations. Atpresent, behaviorofamaant
tumor is notaddressed inthetwo-stagemodel.
In particular, there may be further genetic
alterations necesary for the ability to metasta-
size. It must be noted that cancer can arise in
the absence ofapplication ofa promoter since
normal cell turnover will stil allow for muta-
tion ofDNA by a mutagen. Cancer can also
arise in the absence of a mutagen since
spontaneous DNAmutationsdooccur.
A prediction based on the two-stage
model is that application ofa low dose ofa
mutagen to a benign tumor will greatly
increase malignant conversion ofthe tumor
[so-called initiation-promotion-initiation
(6)]. Experiments have confirmed this pre-
diction (55). It must be stressed that agents
that increase proliferation ofnormal or inter-
mediate tissue will increase cancer risk apart
from anydirect effect on DNA. Such prolif-
eration stimulating agents (promoters are one
class) mayaccount foragreaterproportion of
cancer cases than strictly genotoxic agents in
theenvironment(56).
The darkness ofthe arrows in Figure 1
provides a very rough sense of the relative
probabilities ofthe respective pathways lead-
ing to cancer. There is growing evidence that
cancerarisesfromthemalignantconversionof
asinglecell (57). Ifthis is true, thenalthough
theprobability oftransformation ofa particu-
larcell is extremelylow, theprobabilitythatat
least one cell ofa tissue becomes transformed
is muchhigher. Thedarkestarrowleadsfrom
a normal cell to a normal tissue since this is
the normal process. The probability that at
leastonenormalcellwill becomema ant at
asingle cell division cyde is the product of i1
and P2. Typical mutation rates are approxi-
mately 10-7 percell perdivision (58), so that
even with approximately 1010 cells in a given
tissue, the chance ofa cancer cell arising is
verylow. However, the chance that an inter-
mediate cell will arise is not so low.
Intermediate cells divide as do their normal
counterparts, and they may have a growth
advantage, as when a promoter is applied and
an intermediate lesion appears. Within an
intermediate lesion, the chance that a malig-
nant cell will arise depends on the second
mutation rate and the rate ofdivision ofthe
cellsofthelesion.
Somehereditarycancersyndromes can be
equated to a germ-line mutation with inheri-
tance of all cells in the intermediate stage.
Retinoblastoma is the model for this growing
list ofcancers (59). The Rb gene confers a
100,000-fold increased risk for retinoblas-
toma in those who inherit one absent or
defective homologue. Whereas the probabil-
ity that aparticular cell will suffer the second
mutation and become malignant is very low
(and therefore the syndrome is recessive at
thecellular level), the probabilitythat atleast
one cell of the tissue will suffer the second
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Table 1. Speculative table of how bioeffects of electromagnetic fields might be related to cancer site, time of relevant exposure, cofactors,
and confounders.
Site Time' Cofactors (effect modifiers) Confounders
Transcription/translation Promotion Toxic chemicals
Calcium Acute nonlymphocytic leukemia, Promotion Ionizing radiation; body iron stores Free radical producing
oxygenated tissue (e.g., lung) toxic chemicals
Ornithine decarboxylase Promotion Chemical promoters
Pineal Shiftwork, alcohol,
Cancer cells Estrogen receptor breast Progression light-at-night
Stem cells All breast/prostate Priorto initiation
Immune Non-Hodgkin's lymphoma Progression
aWhen time is prior to initiation, then exposures in the distant past are likelyto be important; when time is progression, then very recent exposures, perhaps even less than 1
year, are likelyto be important.
mutation over the life of the individual is
extremely high, approaching one (and there-
foredominant atthelevel ofthetissue).
Epidemiological Study
Considerations
Consideration ofbiological effects of EMF
suggests particular design features for epi-
demiologic studies (Table 1). Within the
context of the two-stage model described
above, temporal sequence of exposure,
interaction with other agents, and con-
founding factors depend on how EMF is
hypothesized to affect cancer risk.
The lack of direct effects on mutation
suggests that ifEMF increases cancer risk, it
is not by increasing ,l. However, if the
accurate functioning of mitosis is affected,
EMF might indirectly lead to mitotic
recombination, and the fixation of an
antioncogene ifone is involved; an interme-
diate cell may yield a normal and a malig-
nant progeny. In this way, 2 may be
affected and notkl
TimeofExposure
Tamarkin et al. (50) investigated the effect of
melatonin on chemically-induced mammary
cancer in rats. Sixty female Sprague- Dawley
ratsreceived 15 mgof dimethylbenzanthracene
(DMBA) in peanut oil by intragastric intuba-
tion at age 50 days. Following the DMBA
administration, 30 rats receiveddailyinjections
ofmelatonin and 30 receivedvehide injection.
NinetydaysafterDMBAadministration, 50%
of the vehicle-treated rats had developed
tumors,whereas noneofthemelatonin-treated
group had tumors. Melatonin was discontin-
uedinthelattergroup atthis time, andtumors
began to appear later. Their next experiment
examined the effect of reducing melatonin.
Thirty-six pinealectomized and 36 sham-oper-
ated rats received 7 mg of DMBA adminis-
teredasbefore. TwomonthsafterDMBAwas
administered, 48% ofthepinealectomized rats
had mammary tumors, whereas none ofthe
sham group had tumors. By day 240 (termi-
96
nation of the experiment), 88% of the
pinealectomized rats had tumors, whereas
only 22% of the sham group had tumors.
These experimental observations showed that
melatonin suppresses mammary tumorigene-
sis in rats, and lack of melatonin increases
tumorformation.
Despite theanimal and in vitroevidence, it
is not dear that alterations in melatonin affect
risk ofbreast cancer in humans. However, if
suppression ofmelatonin does raise human
breast cancer risk, then the mechanism by
which it acts has important implications for
the conduct ofepidemiological studies ofelec-
tric power. As shown in Figure 2, ifa mecha-
nism of action is by virtue of a general
stimulation ofestrogen production, then the
increased tumoverofthe normal breast epithe-
lial stem cells at riskcould increase cancer risk.
Past exposures to agents such as EMF orlight-
a s n" Increased
estrogen
prolactin
at-night (LAN) that might suppress melatonin
would be important. This can be viewed in
Figure 1 as EMF increasing A, the growth of
normal cells. Exposures as early as puberty
might be crucial. EMF exposure many years
in the past should be assessed if stem cell
turnover isthought tobeaffected.
However, if suppressed melatonin pro-
duction increased breast cancer risk by virtue
of releasing estrogen-receptor positive (ER+)
breast cancer cells from a quiescent state [i.e.,
progression (60)], then very recent exposures
couldbecrucial. Thiswouldbean increase in
C in the two-stage model. Similarly, direct
effects ofEMF on immune cell function (27)
also might increase C. Very recent EMF
exposures should be assessed if cancer-cell
growth is thought to be affected (61).
Perhaps even exposure within one year of
diagnosisshouldbeassessed.
stem cells
> Increased
DMBA mammary
cancer
cancer cells
DMBA -O mammary * Increased survival
cancer cells and growth of
cancer cells
Figure 2. Two possible mechanistic explanations for the observation of Tamarkin et al. (52).
In the first, reduced melatonin leads to an increase in estrogen and/or prolactin that leads to
an increase in the breast epithelial stem cells at risk. This results in increased DMBA-
induced cancer cell production. The second mechanism postulates reduced melatonin lead-
ing to the release of existing DMBA-induced cancer cells from their quiescent state.
Melatonin also may affect the immune function.
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Effects ofEMF on calcium balance that
mightinfluencepromotionviaincreased oxida-
tive stress or disrupted signal transduction
mightaffectthegrowthofinternediate cells, B.
Instudiesofthesepossiblemehanisms, timeof
exposure, cofactors, and cancer types are all
influenced (see below). Similarly, effects on
omithine decarboxylase (ODC) mightaffect B.
Effects on promotion predict a time frame for
relevant exposure that lies between the distant
past and the very recent past, perhaps 2 to 10
yearspnortocancerdiagnosis.
CancerTypes
Certain leukocytes, such as neutrophils and
macrophages, generate oxygen radicals inorder
to kill foreign cells (62). In contrast, cell-
mediated killing by lymphocytes (e.g., cyto-
toxic T-lymphocytes) appears to depend not
on oxidative bursts but rather on the calcium-
dependent release ofa pore-forming protein
that perforates the membrane ofthe target cell
(63). On this basis, nonlymphocytes that use
oxidative bursts for their function may be
moresusceptible tothedisruptionoftheirown
oxidative defence mechanisms than other cell
types. Intracellular calcium concentration and
distribution modulate cellular oxidative activ-
ity, degranulation, phagocytosis, and mobility
(64). Therefore, EMF-induced disruption of
calcium balance and increased oxidative stress
may affect these nonlymphocytes more than
other hematopoietic tissues (65). The obser-
vations ofincreased nonlymphocytic leukemia
in occupational studies of EMF and cancer
(66) are consistent with this possibility. A
study ofresidential EMF exposure and acute
nonlymphocytic leukemia (ANLL) did not
findevidenceforan association (67); however,
occupational exposures were not assessed.
Although carefully done, this study was small
and does not, by itself, offer strong evidence
againstaroleforEMF inadultleukemia.
Calcium is an important second messen-
ger for gene expression; Morgan and Curran
(68) reported that c-fos protooncogene
expression in PC12 cells is induced by either
receptor-ligand interaction or by alterations
of voltage-dependent calcium channels.
There is a report that exposure of human
polymorphonuclear leukocytes to a static
magnetic fieldof0.1 Tdramatically increased
degranulation in a time-dependent manner;
the effect was inhibited by calcium-channel
antagonists (69). A case-control study of
acute nonlymphocytic leukemia in adults
that takes account of both residential and
occupational exposures shouldbeperformed.
There have been three biological effects of
melatonin investigated that might influence
cancerrisk(2) andaccountfortheexperimen-
talobservations ofTamarkin etal. (50), which
showed melatonin inhibited DMBA-induced
mammary carcmogenesis in rats. There is evi-
dence that melatonin can a) stop the growth
ofhormone-dependent cancer cells, b) sup-
press production ofsex hormones (e.g., estro-
gen, testosterone), and c) augment immune
function. Thesethreemechanisms havediffer-
ent implications forcancertypes thatmight be
affected (Fig. 3). IfEMF or LAN suppresses
melatonin and the first mechanism applies,
then riskofhormone-dependent tumors could
be increased (e.g., ER+ breast cancer). Ifthe
secondmechanismapplies, then riskofcancers
oftissues that are dependent on hormones for
growth could be increased (e.g., all tumors of
breast and prostate). Compromise ofimmune
function was long assumed to increase risk for
cancer in general and for all sites. However,
recentevidenceshowsadearandlargeincased
riskonlyofnon-Hodgkin's lymphoma, particu-
larlyofthe brain. There also maybe an eleva-
tion of some mesenchymal tumors and
perhaps melanoma. Itissignificant to this dis-
cussion that the evidence is against a role for
immunologic suppression in the etiology of
most common cancers such as breast and
coloncancer (70).
Among 370 patients diagnosed with
malignant melanoma who were followed
prospectively, a second primary cancer of
breast later developed at a rate six times that
expected (71),which suggests acommonetiol-
ogy for melanoma and breast cancer that may
involve reduced melatonin. Melatonin has
been reported to slow the growth oftrans-
planted melanoma cells in athymic mice (72).
Thus, studies ofbreast cancer and ofmalig-
Figure 3. The cancer types that might be
influenced by agents that suppress mela-
tonin depend on melatonin's action. Thus,
both the timing of exposure and the cancer
site chosen for epidemiological study depend
on the postulated mechanism of action.
nantmelanoma in femalesandin malesandof
prostatecancerinmalesshouldbeperformed.
Cofictors (EffectModifiers)
Calcium is important in many aspects ofcel-
lular physiology, and it plays an important
role as an intracellular messenger for the acti-
vation ofgenes and in intercellular communi-
cation. Calcium homeostasis also is
important forprotection from oxidative stress
(73,74). EMF-induced disruptions of cal-
cium balance that might lead to increases in
free radicals mayinhibit acell's abilityto pro-
tect itselffrom some other oxidative attack
such as a toxic chemical or ionizing radiation.
Many tumor promoters are agents that
increase radical production in cells (75); this
maythen provideamechanism forEMF pro-
motion or copromotion. A proposed test of
whether EMF can increase oxidative stress is
based on a hepatocyte toxicity assay. It was
long speculated that the final event in the
death ofhepatocytes after exposure to toxins
was the influx of extracellular calcium.
However, Smith et al. (76) reported that
incubation offreshly isolated hepatocytes in a
calcium-free medium greatly increased their
susceptibility to damage from carbon te-
trachloride and other hepatotoxins. The cal-
cium-free medium was not itselftoxic in the
absence of the chemical toxins. Reed and
Fariss (77) speculated about these results and
suggested that the calcium-free medium led
to adisruption ofintracellularcalcium, which
led to increased oxidative stress and suscepti-
bility to the toxins. If EMF can disrupt
intracellular calcium balance and lead to
increased oxidative stress, then EMF may
increase the toxicity ofcarbon tetrachloride
to freshly isolatedhepatocytes (65).
Subtle effects ofEMF on calcium home-
ostasis thatmightlead to an increase in oxida-
tive stress could go entirely undetected unless
they occurred in conjunction with another
agent. Bythis mechanism, EMF maystress a
cell not to the point ofdamage but to the
point of increasing susceptibility to other
agents. This reasoning leads to the specula-
tion that EMF, under some circumstances,
might be a radiosensitizer by increasing
oxidative stress and reducing the cellular
complimentofreducingequivalents (65).
Increases in oxidative stress could pro-
mote or copromote by increasing B, the
growth rate of intermediate cells. Balcer-
Kubiczek and Harrison (78) used a transfor-
mation assay of C3H/1OT1/2 cells to
determine the interactions ofan X-ray, TPA,
and a 2.45-GHz microwave pulse modulated
at 120 Hz. They found that the microwave
alone had no effect and did not increase the
effect ofthe X-ray. However, the microwave
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significantly increased transformation when
used in combination with theX-rayandTPA
as compared to the X-ray plus TPA without
microwave. In addition, microwave and
TPA together increased transformation in the
absence ofthe X-ray, neither increased trans-
formation alone. Stuchly et al. (79) have
reported copromotion by magnetic fields in
themouseskin.
Adey (80,81) suggested a synergism of
EMF with chemical tumor promoters that
leads to autonomous cell growth via dis-
ruptions of intercellular communication.
Recent data in support of this speculation
(82) showed that intermittent exposure to a
1-G, 60-Hz magnetic field significantly
increased the expression of transformation
byTPAofC3H/lOT1/2 fibroblasts.
Another possible cofactor for oxidative
stress resulting from effects on calcium bal-
ance is body iron stores. There is evidence
thathigh bodyiron stores increase cancer risk
(83), and the role ofiron in catalyzing oxy-
gen radicals is one possible mechanism (65).
Phillips etal. (84) reportedthatexposure to a
60-Hz magnetic field or to a combined elec-
tric and magnetic field produced constitutive
expression oftransferrin receptors on human
colon cancercells in vitro.
Finally, EMF-induced loss ofiron from
its intracellularstorage protein, ferritin, might
increase oxidative stress. Therefore, higher
iron might increase the effect ofany EMF
increases in oxidative stress due to disruption
ofcalcium, and, in contrast, EMF itselfmay
increase reactive iron availability within the
cell and cause further oxidative stress. There
is a need for a study ofEMF effects on sus-
ceptibility to radiation-induced cancer and
cancer induced by chemicals that increase
oxidative stress. Body iron stores also should
beassessed inthesestudies.
Confounding
The group ofconfounders that are based on
increased oxidative stress from disruption of
calcium balance would include chemicals
associated with occupational exposure to
EMF. These would be chemicals that are
known or suspected to derive their toxicity in
whole or in part from generation offree radi-
cals. These chemicals may also be cofactors
(effectmodifiers) as opposedto confounders.
In studies of leukemia, detailed infor-
mation on exposure to agents that might
increase oxidative stress should be gathered.
Ifpossible, biomarkers ofexposure to these
agents should be used in these studies.
IfEMF is thought to increase cancer risk
via an effect on pineal function, then possi-
ble confounders include LAN, shift work,
alcohol consumption, and any other factor
that has been shown to affect pineal func-
tion. These factors should be taken into
account in epidemiological studies ofEMF.
Also, in studies of breast and prostate
cancers, other agents that affect pineal
function should be assessed.
Future Directions
Epidemiology can be conducted fruitfully
in the absence of a biological rationale.
Without much understanding ofwhat was
bad about cigarette smoke, early studies of
smoking and lung cancer made great con-
tributions to understanding people's health
and eventually improving it. However, a
biological rationale can aid in designing
epidemiological studies, particularly in an
area such as electric power and cancer,
because the design is so challenging. In
studies of smoking, it is simple and rela-
tively inexpensive to gather data, because
the answer to a question can yield good
exposure information. There are also bio-
markers of recent exposure to cigarette
smoke. However, it is verydifficult to assess
exposure to EMF (even if there were con-
sensus on what constitutes a relevant expo-
sure); questionnaires are oflimited use, and
there is no identifiable biomarker ofexpo-
sure. Therefore, biological considerations
enable focused epidemiological studies of
specific hypotheses.
There is a place for both epidemiological
and laboratory studies in most research pro-
grams into the causes ofcancer; there should
be synergy between the two. Epidemiology
can address directly the question ofwhether
increased risk of cancer is associated with
some aspect ofthe human environment such
as exposure to EMF. These studies are nec-
essarily crude and can rarely determine pre-
ciselywhat component ofthe exposure is the
culprit because pure, single-agent exposures
in human populations are virtually nonexis-
tent. EMF is too broad adefinition ofexpo-
sure in epidemiological studies to be very
helpful in mitigating exposure, and there is
no doubt that electricity will continue to be
used whether or not a consensus eventually
emerges from epidemiology that EMF
increases cancer risk. However, laboratory
studies can address what can bedone about a
problem ofincreased cancer risk by isolating
what component of exposure causes the
problem. Iflaboratory studies could isolate
successfully a particular feature of exposure
to EMF that accounted for an increased risk
ofcancer, then mitigation ofexposure to that
feature might be feasible. The reverse also is
true: Laboratory studies can identify previ-
ously unsuspected cancer-causing agents that
shouldbeinvestigated epidemiologically.
Biological considerations for epidemio-
logical studies are illustrated in Table 1.
This table is speculative and selective. It is
not intended to exclude any ideas on possi-
ble EMF studies. Rather, it is intended to
provide an example of the kind of reason-
ing that might go from biological rationale
to epidemiological design.
Suggested new avenues for study include
hormone-dependent cancers and cancers of
hormone-dependent tissues, increased sus-
ceptibility to radiation-induced cancer, and
increasedsusceptibility tofr-radical producing
toxic chemicals. 4
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